Provided by Tiger Trade Technology Pte. Ltd.

Novartis AG

132.57
+0.21000.16%
Post-market: 132.570.00000.00%19:11 EST
Volume:1.23M
Turnover:162.28M
Market Cap:256.64B
PE:18.16
High:133.01
Open:132.37
Low:131.77
Close:132.36
52wk High:134.24
52wk Low:96.06
Shares:1.94B
Float Shares:1.84B
Volume Ratio:0.58
T/O Rate:0.07%
Dividend:3.86
Dividend Rate:2.91%
EPS(TTM):7.30
EPS(LYR):5.92
ROE:32.62%
ROA:12.13%
PB:5.79
PE(LYR):22.41

Loading ...

Roche's Oral Breast Cancer Drug Shows 30% Drop In Recurrence In Patients With Early Disease

Benzinga_recent_news
·
Dec 12

Cancer Study Buoys These Small Biotechs -- Barrons.com

Dow Jones
·
Dec 10

Novartis Says 1 in 4 Breast Cancer Patients Treated With Kisqali Progression-Free Beyond 4 Years

MT Newswires Live
·
Dec 09

Novartis Says Phase 3 Ianalumab Study Showed Extended Immune Thrombocytopenia Disease Control

MT Newswires Live
·
Dec 09

Tiny Biotech Terns Takes Aim At Novartis' Leukemia Blockbuster

Benzinga_recent_news
·
Dec 09

Novartis to Collaborate With Relation to Discover New Atopic Disease Targets

MT Newswires Live
·
Dec 09

Novartis AG (NVS.US) Bets $1.7 Billion on UK AI Biotech to Target Allergic Diseases

Stock News
·
Dec 09

Novartis Shares Rise After Morgan Stanley Upgrade

MT Newswires Live
·
Dec 04

Top Calls on Wall Street: Nvidia, Apple, Amazon, Oracle, Marvell, Broadcom, ASML, American Eagle, and More

Tiger Newspress
·
Dec 03

Morgan Stanley Upgrades Novartis to Overweight From Equal Weight, $136 Price Target

MT Newswires Live
·
Dec 03

U.S., U.K. Strike Deal on Higher Drug Prices -- WSJ

Dow Jones
·
Dec 02

FDA Decision Opens Bigger Market for Novartis's Blockbuster Gene Therapy -- Barrons.com

Dow Jones
·
Nov 26

Sector Update: Health Care Stocks Edge Higher Premarket Tuesday

MT Newswires Live
·
Nov 25

Top Calls on Wall Street: Nvidia, Apple, Tesla, Microsoft, Oracle, Vistra Energy, Coinbase & More

Tiger Newspress
·
Nov 25

Market Chatter: Novartis to Eliminate Up to 550 Roles at Stein Facility in Switzerland

MT Newswires Live
·
Nov 25

Novartis Drug for Spinal Muscular Atrophy Gets FDA Approval

Dow Jones
·
Nov 25

J.P. Morgan Sticks to Its Hold Rating for Novartis (NVS)

TIPRANKS
·
Nov 21

Biotech Reawakens: Policy Clarity, Breakthrough Data and a Surge in M&A

LiveWire
·
Nov 21

Novartis Projects Faster Growth Through 2030 After Raising Drug Forecasts

Benzinga
·
Nov 21

Exchange-Traded Funds, Equity Futures Higher Pre-Bell Thursday Ahead of Jobs Data

MT Newswires Live
·
Nov 20